Accessibility Menu
 
Regenicin logo

Regenicin

(OTC) RGIN

Current Price$0.00
Market Cap$15,300
Since IPO (2009)-100%
5 Year-99%
1 Year+0%
1 Month+9,900%

Regenicin Financials at a Glance

Market Cap

$15,300

Revenue (TTM)

$0.00

Net Income (TTM)

$968.09K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

17.81 (High)

Price

$0.00

Volume

3,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.75

RGIN News

No articles available.

RGIN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Regenicin

Industry

Biotechnology

Employees

3

CEO

Randall E. McCoy

Headquarters

Little Falls, NJ 07424, US

RGIN Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

11%

Return on Assets

-41%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$15.30K

Shares Outstanding

153.48M

Volume

3.00K

Short Interest

0.00%

Avg. Volume

2.98K

Financials (TTM)

Gross Profit

$601.00K

Operating Income

$601.00K

EBITDA

$601.00K

Operating Cash Flow

$27.29K

Capital Expenditure

$0.00

Free Cash Flow

$27.29K

Cash & ST Invst.

$15.49K

Total Debt

$642.92K

Regenicin Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2023YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$15.30K

N/A

Market Cap/Employee

$5.10K

N/A

Employees

3

N/A

Net Income

$336.44K

-99.1%

EBITDA

$326.54K

-109.3%

Quarterly Fundamentals

Name
Q2 2023YOY CHG

Net Cash

$11.22M

+1920.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$642.92K

+3.7%

Return on Assets

-41.24%

N/A

Return on Invested Capital

10.74%

N/A

Free Cash Flow

$328.28K

-4939.6%

Operating Cash Flow

$328.28K

-4939.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AOLSAeolus Pharmaceuticals, Inc.
$0.00+0.00%
VOQPVioQuest Pharmaceuticals, Inc.
$0.00+0.00%
QBIOQ BioMed Inc.
$0.00+0.00%
SCPSScopus BioPharma Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$43.87-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%

Questions About RGIN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.